GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (HKSE:01358) » Definitions » Revenue

PW Medtech Group (HKSE:01358) Revenue : HK$738.4 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group Revenue?

PW Medtech Group's revenue for the six months ended in Dec. 2023 was HK$389.5 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$738.4 Mil. PW Medtech Group's Revenue per Share for the six months ended in Dec. 2023 was HK$0.25. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.47.

During the past 12 months, the average Revenue per Share Growth Rate of PW Medtech Group was 23.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 36.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 15.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was -2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 12 years, PW Medtech Group's highest 3-Year average Revenue per Share Growth Rate was 36.20% per year. The lowest was -21.70% per year. And the median was -2.00% per year.


PW Medtech Group Revenue Historical Data

The historical data trend for PW Medtech Group's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PW Medtech Group Revenue Chart

PW Medtech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 403.02 293.22 332.32 599.48 738.39

PW Medtech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 168.86 251.14 360.23 348.93 389.46

Competitive Comparison of PW Medtech Group's Revenue

For the Medical Instruments & Supplies subindustry, PW Medtech Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PW Medtech Group's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Revenue distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's Revenue falls into.



PW Medtech Group Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$738.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PW Medtech Group  (HKSE:01358) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


PW Medtech Group Revenue Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PW Medtech Group (HKSE:01358) Business Description

Traded in Other Exchanges
Address
Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.
Executives
Right Faith Holdings Limited 2101 Beneficial owner
Chan Marc 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc 2101 Beneficial owner
Cross Mark Limited 2101 Beneficial owner
Liu Yufeng 2201 Interest of corporation controlled by you
Zhang Zaixian 2202 Interest of your spouse

PW Medtech Group (HKSE:01358) Headlines

No Headlines